Incidence of and risk factors for neonatal jaundice among newborns in southern Nepal

Tropical Medicine and International Health

Volumn 18, Issue 11, 2013, Pages 1317-1328

  Scrafford, Carolyn G ^a   Mullany, Luke C ^a   Katz, Joanne ^a   Khatry, Subarna K ^a,b   Leclerq, Steven C ^a,b   Darmstadt, Gary L ^c   Tielsch, James M ^d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Nepal Nutrition Intervention Project Sarlahi   (Nepal)

^c BILL AND MELINDA GATES FOUNDATION   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Developing country; Neonatal jaundice; Nepal; Risk factors

Indexed keywords

CHLORHEXIDINE; OIL;

BREASTFEEDING; CHILD HEALTH; DISEASE INCIDENCE; HEALTH CARE; HEALTH RISK; HEALTH SERVICES; MORTALITY; POISSON RATIO; REGRESSION ANALYSIS; RISK FACTOR;

AIR TEMPERATURE; AMBIENT AIR; ARTICLE; BIRTH WEIGHT; BREAST FEEDING; CLEANING; CLINICAL ASSESSMENT; COLOR; COLOSTRUM; DELIVERY; EDUCATION; ETHNICITY; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HIGH BIRTH WEIGHT; HOUSEHOLD; HUMAN; INCIDENCE; INFANT; INFANT FEEDING; LABOR; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; MASSAGE; NEPAL; NEWBORN; NEWBORN JAUNDICE; NEWBORN MORBIDITY; NEWBORN MORTALITY; PATIENT REFERRAL; PRIMIPARA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; RURAL AREA; SEX; SOCIOECONOMICS;

NEPAL;

DEVELOPING COUNTRY; NEONATAL JAUNDICE; NEPAL; RISK FACTORS;

BIRTH WEIGHT; BREAST FEEDING; EDUCATIONAL STATUS; ETHNIC GROUPS; FEEDING BEHAVIOR; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; JAUNDICE, NEONATAL; MALE; MASSAGE; MIDWIFERY; NEPAL; OBSTETRIC LABOR COMPLICATIONS; PARITY; PERINATAL CARE; POVERTY; PREGNANCY; RISK FACTORS; RURAL POPULATION; SEX FACTORS; TEMPERATURE;

EID: 84886245415     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12189     Document Type: Article

References (44)

1. AAP Subcommittee on Hyperbilirubinemia (2004) Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114, 297-316.
2. AAP Subcommittee on Neonatal Hyperbilirubinemia (2001) Neonatal jaundice and kernicterus. Pediatrics 108, 763-765.
3. AAP Subcommittee on Hyperbilirubinemia (2004) Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114, 297-316.
4. Beachy JM (2007) Investigating jaundice in the newborn. Neonatal Network 26, 327-333.
5. Beutler E, Gaetani G, der Kaloustian V, Luzzatto L, Niwa S, Pannich V, Sodeinde O, Belsey M, Kuliev AM, Modell B & Shah PM (1989) Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group. Bulletin of the World Health Organization 67, 601-611.
6. Bhutani VK (2012) Editorial: building evidence to manage newborn jaundice worldwide. Indian Journal of Pediatrics 79, 253-255.
7. Bhutani VK & Johnson L (2006) Kernicterus in late preterm infants cared for as term healthy infants. Seminars in Perinatology 30, 89-97.
8. Bracci R, Buonocore G, Garosi G, Bruchi S & Berni S (1989) Epidemiologic study of neonatal jaundice. A survey of contributing factors. Acta Paediatrica Scandinavica. Supplement 360, 87-92.
9. Cappellini MD & Fiorelli G (2008) Glucose-6-phosphate dehydrogenase deficiency. Lancet 371, 64-74.
10. Chawla D, Jain S, Dhir S & Rani S (2011) Risk assessment strategy for prediction of pathological hyperbilirubinemia in neonates. Indian Pediatrics 79, 198-201.
11. Cohen SM (2006) Jaundice in the full-term newborn. Pediatric Nursing 32, 202-208.
12. Darcy AE (2009) Complications of the late preterm infant. Journal of Perinatal and Neonatal Nursing 23, 78-86.
13. Geiger AM, Petitti DB & Yao JF (2001) Rehospitalisation for neonatal jaundice: risk factors and outcomes. Paediatric and Perinatal Epidemiology 15, 352-358.
14. Goswami V, Dutta AK, Singh V & Chandra J (2006) Evaluation of simple clinical signs of illness in young infants (0-2 months) and its correlation with WHO IMCI algorithm (7 days to 2 months). Indian Pediatrics 43, 1042-1049.
15. Hameed NN, Na'Ma AM, Vilms R & Bhutani VK (2011) Severe neonatal hyperbilirubinemia and adverse short-term consequences in Baghdad, Iraq. Neonatology 100, 57-63.
16. Huang MJ, Kua KE, Teng HC, Tang KS, Weng HW & Huang CS (2004) Risk factors for severe hyperbilirubinemia in neonates. Pediatric Research 56, 682-689.
17. Huang A, Tai BC, Wong LY, Lee J & Yong EL (2009) Differential risk for early breastfeeding jaundice in a multi-ethnic Asian cohort. Annals of the Academy of Medicine, Singapore 38, 217-224.
18. Ip S, Chung M, Kulig J et al. (2004) An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 114, e130-e153.
19. Kaini NR, Chaudhary D, Adhikary V, Bhattacharya S & Lamsal M (2006) Overview of cases and prevalence of jaundice in neonatal intensive care unit. Nepal Medical College journal 8, 133-135.
20. Karas DJ, Mullany LC, Katz J, Khatry SK, LeClerq SC & Darmstadt GL (2012) Home care practices for newborns in rural southern Nepal during the first 2 weeks of life. Journal of Tropical Pediatrics 58, 200-207.
21. Kaur S, Chawla D, Pathak U & Jain S (2012) Predischarge non-invasive risk assessment for prediction of significant hyperbilirubinemia in term and late preterm neonates. Journal of Perinatology 32, 716-721.
22. Liu L, Johnson HL, Cousens S et al. (2012) Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379, 2151-2161.
23. Maisels MJ (1987). Neonatal jaundice. In: Neonatology, 3rd edn. (ed. GB Avery ) Lippincott, Philadelphia, pp. 534-629.
24. Maisels MJ (2006a) What's in a name? Physiologic and pathologic jaundice: the conundrum of defining normal bilirubin levels in the newborn. Pediatrics 118, 805-807.
25. Maisels MJ (2006b) Neonatal jaundice. Pediatrics in Review 27, 443-454.
26. Maisels MJ & Kring E (1998) Length of stay, jaundice, and hospital readmission. Pediatrics 101, 995-998.
27. Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR & Watchko JF (2009) Hyperbilirubinemia in the newborn infant ≥ 35 weeks' gestation: an update with clarifications. Pediatrics 124, 1193-1198.
28. Mullany LC, Darmstadt GL, Khatry SK et al. (2006) Topical applications of chlorhexidine to the umbilical cord for prevention of omphalitis and neonatal mortality in southern Nepal: a community-based, cluster-randomised trial. Lancet 367, 910-918.
29. Mullany LC, Katz J, Li YM et al. (2008) Breast-feeding patterns, time to initiation, and mortality risk among newborns in southern Nepal. Journal of Nutrition 138, 599-603.
30. Newman TB, Xiong B, Gonzales VM & Escobar GJ (2000) Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Archives of Pediatrics and Adolescent Medicine 154, 1140-1147.
31. Nielsen HE, Haase P, Blaabjerg J, Stryhn H & Hilden J (1987) Risk factors and sib correlation in physiological neonatal jaundice. Acta Paediatrica Scandinavica 76, 504-511.
32. Olusanya BO, Akande AA, Emokpae A & Olowe SA (2009) Infants with severe neonatal jaundice in Lagos, Nigeria: incidence, correlates and hearing screening outcomes. Tropical Medicine and International Health 14, 301-310.
33. Sarici SU, Serdar MA, Korkmaz A et al. (2004) Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics 113, 775-780.
34. Schneider AP 2nd (1986) Breast milk jaundice in the newborn. A real entity. JAMA 255, 3270-3274.
35. Seidman DS, Stevenson DK, Ergaz Z & Gale R (1995) Hospital readmission due to neonatal hyperbilirubinemia. Pediatrics 96(4 Pt 1), 727-729.
36. Sgro M, Campbell D, Barozzino T & Shah V (2011) Acute neurological findings in a national cohort of neonates with severe neonatal hyperbilirubinemia. Journal of Perinatology 31, 392-396.
37. Tielsch JM, Darmstadt GL, Mullany LC et al. (2007) Impact of newborn skin-cleansing with chlorhexidine on neonatal mortality in southern Nepal: a community-based, cluster-randomized trial. Pediatrics 119, e330-e340.
38. Tioseco JA, Aly H, Milner J, Patel K & El-Mohandes AA (2005) Does gender affect neonatal hyperbilirubinemia in low-birth-weight infants? Pediatric Critical Care Medicine 6, 171-174.
39. United Nations (UN) (2008) United Nation's Millennium Development Goals. http://www.un.org/millenniumgoals/childhealth.shtml. (accessed 12 March 2012).
40. Watchko JF (2006a) Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns. Neuromolecular Medicine 8, 513-529.
41. Watchko JF (2006b) Hyperbilirubinemia and bilirubin toxicity in the late preterm infant. Clinics in Perinatology 33, 839-852; abstract ix.
42. Watchko JF (2009) Identification of neonates at risk for hazardous hyperbilirubinemia: emerging clinical insights. Pediatric Clinics of North America 56, 671-687. Table of Contents.
43. Young Infants Clinical Signs Study Group (2008) Clinical signs that predict severe illness in children under age 2 months: a multicentre study. Lancet 371, 135-142.
44. Zou G (2004) A modified Poisson regression approach to prospective studies with binary data. American Journal of Epidemiology 159, 702-706.